Loading…

Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation

Cerebral cavernous malformations (CCMs) are common neurovascular lesions caused by loss-of-function mutations in 1 of 3 genes, including KRIT1 (CCM1), CCM2, and PDCD10 (CCM3), and generally regarded as an endothelial cell-autonomous disease. Here we reported that proliferative astrocytes played a cr...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of clinical investigation 2021-07, Vol.131 (13)
Main Authors: Lopez-Ramirez, Miguel Alejandro, Lai, Catherine Chinhchu, Soliman, Shady Ibrahim, Hale, Preston, Pham, Angela, Estrada, Esau J, McCurdy, Sara, Girard, Romuald, Verma, Riya, Moore, Thomas, Lightle, Rhonda, Hobson, Nicholas, Shenkar, Robert, Poulsen, Orit, Haddad, Gabriel G, Daneman, Richard, Gongol, Brendan, Sun, Hao, Lagarrigue, Frederic, Awad, Issam A, Ginsberg, Mark H
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cerebral cavernous malformations (CCMs) are common neurovascular lesions caused by loss-of-function mutations in 1 of 3 genes, including KRIT1 (CCM1), CCM2, and PDCD10 (CCM3), and generally regarded as an endothelial cell-autonomous disease. Here we reported that proliferative astrocytes played a critical role in CCM pathogenesis by serving as a major source of VEGF during CCM lesion formation. An increase in astrocyte VEGF synthesis is driven by endothelial nitric oxide (NO) generated as a consequence of KLF2- and KLF4-dependent elevation of eNOS in CCM endothelium. The increased brain endothelial production of NO stabilized HIF-1α in astrocytes, resulting in increased VEGF production and expression of a "hypoxic" program under normoxic conditions. We showed that the upregulation of cyclooxygenase-2 (COX-2), a direct HIF-1α target gene and a known component of the hypoxic program, contributed to the development of CCM lesions because the administration of a COX-2 inhibitor significantly prevented the progression of CCM lesions. Thus, non-cell-autonomous crosstalk between CCM endothelium and astrocytes propels vascular lesion development, and components of the hypoxic program represent potential therapeutic targets for CCMs.
ISSN:1558-8238
0021-9738
1558-8238
DOI:10.1172/JCI139570